Cargando…
Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
Non-steroidal anti-inflammatory drugs (NSAIDs) are a chemically diverse class of drugs that target the cyclooxygenase (COX) pathway and have anti-inflammatory, analgesic, and antipyretic properties. Elevated expression of COX-2 has been associated with tumor progression in skin cancer through multip...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289117/ https://www.ncbi.nlm.nih.gov/pubmed/28150108 http://dx.doi.org/10.1007/s13555-016-0166-x |
_version_ | 1782504457849798656 |
---|---|
author | Thomas, Gareth J. Morton, Colin A. |
author_facet | Thomas, Gareth J. Morton, Colin A. |
author_sort | Thomas, Gareth J. |
collection | PubMed |
description | Non-steroidal anti-inflammatory drugs (NSAIDs) are a chemically diverse class of drugs that target the cyclooxygenase (COX) pathway and have anti-inflammatory, analgesic, and antipyretic properties. Elevated expression of COX-2 has been associated with tumor progression in skin cancer through multiple mechanisms. We present evidence for a chemoprotective effect of NSAIDs and discuss potential mechanisms of action of COX-2 in cancer. We also discuss the challenges associated with the treatment of actinic keratosis and the factors that should be taken into consideration when selecting a treatment regimen. A range of treatments are reviewed, with an emphasis on combination therapies. |
format | Online Article Text |
id | pubmed-5289117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-52891172017-02-15 Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis Thomas, Gareth J. Morton, Colin A. Dermatol Ther (Heidelb) Review Non-steroidal anti-inflammatory drugs (NSAIDs) are a chemically diverse class of drugs that target the cyclooxygenase (COX) pathway and have anti-inflammatory, analgesic, and antipyretic properties. Elevated expression of COX-2 has been associated with tumor progression in skin cancer through multiple mechanisms. We present evidence for a chemoprotective effect of NSAIDs and discuss potential mechanisms of action of COX-2 in cancer. We also discuss the challenges associated with the treatment of actinic keratosis and the factors that should be taken into consideration when selecting a treatment regimen. A range of treatments are reviewed, with an emphasis on combination therapies. Springer Healthcare 2017-02-01 /pmc/articles/PMC5289117/ /pubmed/28150108 http://dx.doi.org/10.1007/s13555-016-0166-x Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Thomas, Gareth J. Morton, Colin A. Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis |
title | Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis |
title_full | Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis |
title_fullStr | Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis |
title_full_unstemmed | Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis |
title_short | Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis |
title_sort | cyclooxygenase in cancer prevention and treatments for actinic keratosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289117/ https://www.ncbi.nlm.nih.gov/pubmed/28150108 http://dx.doi.org/10.1007/s13555-016-0166-x |
work_keys_str_mv | AT thomasgarethj cyclooxygenaseincancerpreventionandtreatmentsforactinickeratosis AT mortoncolina cyclooxygenaseincancerpreventionandtreatmentsforactinickeratosis |